Iovance biotherapeutics to host virtual roundtable with key opinion leaders to discuss melanoma treatment landscape

San carlos, calif., june 20, 2023 (globe newswire) -- iovance biotherapeutics, inc. (nasdaq: iova), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (til) therapies for patients with cancer, will host an investor conference call and webcast to discuss lifileucel til therapy and the emerging melanoma treatment landscape on june 26, 2023, at 5:00 p.m.
IOVA Ratings Summary
IOVA Quant Ranking